Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitochondrial membrane potential
Authors:
- 18 August 2022
- journal article
- research article
- Published by Elsevier in Toxicology in Vitro
- Vol. 84, 105458
Abstract
No abstract availableKeywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticalsCancer Letters, 2017
- Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and AdvancementsBioMed Research International, 2017
- Tomentosin Induces Telomere Shortening and Caspase‐Dependant Apoptosis in Cervical Cancer CellsJournal of Cellular Biochemistry, 2016
- More deaths from pancreatic cancer than breast cancer in the EU by 2017Acta Oncologica, 2016
- Reactive Oxygen Species and Targeted Therapy for Pancreatic CancerOxidative Medicine and Cellular Longevity, 2016
- Gemcitabine resistance in pancreatic ductal adenocarcinomaDrug Resistance Updates, 2015
- Suppressive Effect of Tomentosin on the Production of Inflammatory Mediators in RAW264.7 CellsBiological and Pharmaceutical Bulletin, 2014
- Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosisBMC Cell Biology, 2013
- Apoptolidin: Induction of Apoptosis by a Natural ProductAngewandte Chemie International Edition, 2006
- Mitochondrial control of apoptosis: an introductionBiochemical and Biophysical Research Communications, 2003